Massachusetts Institute of Technology

MIT Technology Licensing Office

Technology
Licensing
Office
  • Disclose & Protect Your Intellectual Property
    • Submit Your Disclosure
    • Disclosure FAQs
    • Share Research Materials
      • Incoming MTA Requests
    • Forms that Protect IP Rights
  • Learn About Intellectual Property
    • Technology Transfer Overview
    • Technology Transfer Process
    • Ownership
      • Inventions and Proprietary Information Agreement (IPIA)
      • Assigning Back Ownership
      • IPIA Obligations for IPIA Signatories
      • IPIA FAQs
    • MIT IP Policy & FAQs
    • Patenting an Invention
    • Conduct Your Own Patent Search
    • Software and Open Source Licensing
      • Open Source Licensing
    • Commercializing an Invention
    • Lincoln Laboratory
    • Information for Students
      • IP Considerations for MIT $100K Competitors
    • Licensing MIT's Intellectual Property
  • Explore MIT Technologies
    • View Technologies
      • Ready to Sign License Technologies
      • Ready To Sign License Instructions
    • Sponsoring Research
  • Trademark & Merchandise
    • License MIT's Trademark
    • Merchandise
    • Using MIT's Name
  • Resources
    • Licensing to Startups
    • Payment FAQs for Licensees
    • News & Events
      • 2023 MIT Excellence Award
      • Office Updates
      • Representative Term Sheet for Launching Life Science Startups
      • Updates on Research Administration
    • 2023 IAP Golden Speaker Series
      • Golden Speaker Series Live Stream Recording
    • 2023 IAP Intellectual Property Speaker Series
    • Educational Resources
      • TLO Seminar Series
  • Engage with the TLO
    • About the TLO
    • Our Team
    • Contact Us
      • In-Person Office Hours
      • Virtual Office Hours
      • Join Our Mailing List
    • Career Opportunities
    • Internship Program
      • Internship Application
    • TLO Organization Chart
    • TLO Data
      • TLO Statistics
    • Shirley Transformation Project
    • COVID-19
      • COVID-19 Technology Access Framework
All Menu Items
  • Disclose & Protect Your Intellectual Property
    • Submit Your Disclosure
    • Disclosure FAQs
    • Share Research Materials
      • Incoming MTA Requests
    • Forms that Protect IP Rights
  • Learn About Intellectual Property
    • Technology Transfer Overview
    • Technology Transfer Process
    • Ownership
    • MIT IP Policy & FAQs
    • Patenting an Invention
    • Conduct Your Own Patent Search
    • Software and Open Source Licensing
    • Commercializing an Invention
    • Lincoln Laboratory
    • Information for Students
    • Licensing MIT's Intellectual Property
  • Explore MIT Technologies
    • View Technologies
    • Sponsoring Research
  • Trademark & Merchandise
    • License MIT's Trademark
    • Merchandise
    • Using MIT's Name
  • Resources
    • Licensing to Startups
    • Payment FAQs for Licensees
    • News & Events
    • 2023 IAP Golden Speaker Series
    • 2023 IAP Intellectual Property Speaker Series
    • Educational Resources
  • Engage with the TLO
    • About the TLO
    • Our Team
    • Contact Us
    • Career Opportunities
    • Internship Program
    • TLO Organization Chart
    • TLO Data
    • Shirley Transformation Project
    • COVID-19

Chemotherapy

An Oxaliplatin Crosslinker for the Formation of Drug Delivery Nanoparticles

Header and Body 1
Header and Body 2
Header and Body 3
Header and Body 4
  • Read more about An Oxaliplatin Crosslinker for the Formation of Drug Delivery Nanoparticles

M13 Phage Assembly System for Optimal Blood Trafficking, Tumor Penetration, and Passage Across the Blood Brain Barrier

Header and Body 1
Header and Body 2
Header and Body 3
Header and Body 4
  • Read more about M13 Phage Assembly System for Optimal Blood Trafficking, Tumor Penetration, and Passage Across the Blood Brain Barrier

G-CSF Analog Compositions and Methods

Header and Body 1
Header and Body 2
Header and Body 3
Header and Body 4
  • Read more about G-CSF Analog Compositions and Methods

Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-negative Breast Cancer

Header and Body 1
Header and Body 2
Header and Body 3
Header and Body 4
  • Read more about Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-negative Breast Cancer
Subscribe to RSS - Chemotherapy

Massachusetts Institute of Technology

MIT Technology Licensing Office

Technology
Licensing
Office

Technology Licensing Office

255 Main Street, Room NE18-501

Cambridge, MA 02142-1601

Contact Us Accessibility

© 2023 Massachusetts Institute of Technology